B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid TumorsZongliang Zhang, Aiping Tong, Caiying Jiang et al.|Molecular Therapy — Oncolytics|2020Cited by 142
Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningiomaXin Tang, Liangxue Zhou, Zongliang Zhang et al.|Clinical & Translational Immunology|2020Cited by 75
Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell LymphomaMeijun Zheng, Hui Yang, Lingyu Yu et al.|Translational Oncology|2020Cited by 37
Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacyCheng Huang, Gang Guo, Hongjian Li et al.|Theranostics|2020Cited by 22
Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cellsShasha Zhao, Aiping Tong, Yuelong Wang et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 18